Amarin Corp Plcuk (AMRN) Cash from Operations (2010 - 2026)

Amarin Corp Plcuk (AMRN) posted quarterly Cash from Operations of 6388000.0 for Q1 2026, up 151.27% YoY from 2542263.21 in Q1 2025, and down 58.19% sequentially from 15278000.0 in Q4 2025.

Amarin Corp Plcuk (AMRN) Cash from Operations (2010 - 2026) Analysis & Trends

Amarin Corp Plcuk has disclosed Cash from Operations across 17 years of filings, most recently posting 6388000.0 for Q1 2026.

  • In Q1 2026, Cash from Operations rose 151.27% year-over-year to 6388000.0; the TTM figure through Mar 2026 stood at 25575000.0 (up 182.83% YoY), while the FY2025 annual figure was 6728000.0, up 121.69% from the prior year.
  • Cash from Operations fell to 6388000.0 in Q1 2026, from 15278000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for AMRN reached as high as 16606000.0 in Q2 2025 and fell as low as 98847000.0 in Q1 2022.
  • The 5-year median for Cash from Operations is 2749000.0 (2024), against an average of 11242117.65.
  • Annual changes were most pronounced in 2024 — Cash from Operations tumbled 1963.57% — and 2025, when it soared 704.07%.
  • A 5-year view of Cash from Operations shows it stood at 1552000.0 in 2022, then tumbled by 141.56% to 645000.0 in 2023, then plunged by 1963.57% to 13310000.0 in 2024, then jumped by 214.79% to 15278000.0 in 2025, then slumped by 58.19% to 6388000.0 in 2026.
  • According to Business Quant data, Cash from Operations over the past three periods registered 6388000.0, 15278000.0, and 12697000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 5.33 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 2.51 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 3.83 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 3.92 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 2.19 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 2.54 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 2.62 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn 6.39 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 6.39 Mn
Mar 31, 2026 6.39 Mn
Dec 31, 2025 15.28 Mn
Dec 31, 2025 15.28 Mn
Sep 30, 2025 -12.70 Mn
Sep 30, 2025 -12.70 Mn
Jun 30, 2025 16.61 Mn
Jun 30, 2025 16.61 Mn
Mar 31, 2025 -12.46 Mn
Mar 31, 2025 -12.46 Mn
Dec 31, 2024 -13.31 Mn
Dec 31, 2024 -13.31 Mn
Sep 30, 2024 -2.36 Mn
Sep 30, 2024 -2.36 Mn
Jun 30, 2024 -2.75 Mn
Jun 30, 2024 -2.75 Mn
Mar 31, 2024 -12.60 Mn
Mar 31, 2024 -12.60 Mn
Dec 31, 2023 -645,000.00
Dec 31, 2023 -645,000.00